Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study

Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study

Abstract Background Previous studies have suggested an association between the use of direct‐acting antiviral agents (DAAs) for treating hepatitis C virus (HCV) infection and the resulting decrease in the incidence of hepatocellular carcinoma (HCC); however, it is unclear whether DAAs prevent the re...

Full description

Bibliographic Details
Main Authors: Masahito Nakano, Hironori Koga, Tatsuya Ide, Ryoko Kuromatsu, Satoru Hashimoto, Hiroshi Yatsuhashi, Masataka Seike, Nobito Higuchi, Makoto Nakamuta, Satoshi Shakado, Shotaro Sakisaka, Satoshi Miuma, Kazuhiko Nakao, Yoko Yoshimaru, Yutaka Sasaki, Satoshi Oeda, Yuichiro Eguchi, Yuichi Honma, Masaru Harada, Kenji Nagata, Seiichi Mawatari, Akio Ido, Tatsuji Maeshiro, Shuichi Matsumoto, Yuko Takami, Tetsuo Sohda, Takuji Torimura
Format: Article
Language:English
Published: Wiley 2019-05-01
Series:Cancer Medicine
Subjects:
DAA
HCV
hepatocarcinogenesis
liver cancer
SVR
Online Access:https://doi.org/10.1002/cam4.2061

Similar Items

Similar Items